Uroš Smrdel

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor

Uroš Smrdel, Mara Popović, Matjaž Zwitter et al. · Radiology and Oncology · 2015 · 65 citations · Full text

Medicine, Genetics, Oncology +17

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma

Viljem Kovač, Matjaž Zwitter, Mirjana Rajer et al. · Anti-Cancer Drugs · 2011 · 41 citations

Medicine, Oncology, Pharmacotherapy +16

Phase I???II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer

Matjaž Zwitter, Viljem Kovač, Uroš Smrdel et al. · Anti-Cancer Drugs · 2005 · 37 citations

Medicine, Oncology, Pharmacotherapy +14

Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial

Matjaž Zwitter, Viljem Kovač, Mirjana Rajer et al. · Anti-Cancer Drugs · 2010 · 30 citations

Medicine, Oncology, Pharmacotherapy +13

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II Clinical Trial

Matjaž Zwitter, Viljem Kovač, Uroš Smrdel et al. · Journal of Thoracic Oncology · 2009 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15